GMG
Clinical trials for GMG explained in plain language.
Never miss a new study
Get alerted when new GMG trials appear
Sign up with your email to follow new studies for GMG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Extended safety check for Kids' Muscle-Weakening disease treatment
Disease control ENROLLING_BY_INVITATIONThis study aims to monitor the long-term safety of efgartigimod, a medication for generalized myasthenia gravis (gMG), in children who participated in earlier trials. It will follow up to 12 young participants who received either intravenous or subcutaneous injections of the drug…
Matched conditions: GMG
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Apr 02, 2026 03:56 UTC
-
New treatment tested for rare childhood Muscle-Weakening disease
Disease control OngoingThis study is testing whether ravulizumab, an intravenous medication, can help control symptoms of generalized myasthenia gravis in children aged 6 to 18. Researchers will measure how the drug works in the body and whether it improves muscle strength and daily activities. The stu…
Matched conditions: GMG
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 02, 2026 03:56 UTC
-
New drug trial aims to control debilitating muscle disease
Disease control OngoingThis study is testing whether an intravenous drug called efgartigimod is effective and safe for adults with a specific, hard-to-treat form of generalized myasthenia Gravis (gMG). About 119 participants will be randomly assigned to receive either the drug or a placebo for part of …
Matched conditions: GMG
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC